Vitiello A, Blasi F, Sabbatucci M, Zovi A, Miele F, Ponzo A
J Clin Med. 2024; 13(6).
PMID: 38541936
PMC: 10970943.
DOI: 10.3390/jcm13061711.
Sanchez H, OToole G, Berwin B
Microbiol Spectr. 2023; 11(4):e0166723.
PMID: 37470715
PMC: 10434018.
DOI: 10.1128/spectrum.01667-23.
Sanchez H, OToole G, Berwin B
bioRxiv. 2023; .
PMID: 37131708
PMC: 10153242.
DOI: 10.1101/2023.04.20.537720.
Finbloom J, Raghavan P, Kwon M, Kharbikar B, Yu M, Desai T
Sci Adv. 2023; 9(3):eade8039.
PMID: 36662850
PMC: 9858510.
DOI: 10.1126/sciadv.ade8039.
Chatterjee S, Das S, Paul P, Chakraborty P, Sarkar S, Das A
Folia Microbiol (Praha). 2022; 68(1):151-163.
PMID: 36192618
DOI: 10.1007/s12223-022-01005-z.
Therapeutic evaluation of immunomodulators in reducing surgical wound infection.
Mahmud F, Roy R, Mohamed M, Aboonabi A, Moric M, Ghoreishi K
FASEB J. 2021; 36(1):e22090.
PMID: 34907595
PMC: 9058973.
DOI: 10.1096/fj.202101019R.
Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections.
Ham S, Kim H, Jo M, Lee J, Byun Y, Ko G
Microbiol Spectr. 2021; 9(2):e0019221.
PMID: 34704784
PMC: 8549756.
DOI: 10.1128/Spectrum.00192-21.
Population Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis.
Praet A, Bourguignon L, Vetele F, Breant V, Genestet C, Dumitrescu O
Antimicrob Agents Chemother. 2021; 65(10):e0073721.
PMID: 34280011
PMC: 8448147.
DOI: 10.1128/AAC.00737-21.
Computationally designed pyocyanin demethylase acts synergistically with tobramycin to kill recalcitrant biofilms.
VanDrisse C, Lipsh-Sokolik R, Khersonsky O, Fleishman S, Newman D
Proc Natl Acad Sci U S A. 2021; 118(12).
PMID: 33723058
PMC: 8000102.
DOI: 10.1073/pnas.2022012118.
Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions.
Magreault S, Roy C, Launay M, Sermet-Gaudelus I, Jullien V
Clin Pharmacokinet. 2021; 60(4):409-445.
PMID: 33486720
DOI: 10.1007/s40262-020-00981-0.
Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
Armijo L, Wawrzyniec S, Kopciuch M, Brandt Y, Rivera A, Withers N
J Nanobiotechnology. 2020; 18(1):35.
PMID: 32070354
PMC: 7029462.
DOI: 10.1186/s12951-020-0588-6.
Cold plasma effect on the proteome of Pseudomonas aeruginosa - Role for bacterioferritin.
Yau K, Murphy A, Zhong L, Mai-Prochnow A
PLoS One. 2018; 13(10):e0206530.
PMID: 30365553
PMC: 6203385.
DOI: 10.1371/journal.pone.0206530.
Surfactant-induced Marangoni transport of lipids and therapeutics within the lung.
Stetten A, Iasella S, Corcoran T, Garoff S, Przybycien T, Tilton R
Curr Opin Colloid Interface Sci. 2018; 36:58-69.
PMID: 30147429
PMC: 6103298.
DOI: 10.1016/j.cocis.2018.01.001.
Evaluation of Biofilm Formation and Frequency of Multidrug-resistant and Extended Drug-resistant Strain in Isolated from Burn Patients in Isfahan.
Nasirmoghadas P, Yadegari S, Moghim S, Esfahani B, Fazeli H, Poursina F
Adv Biomed Res. 2018; 7:61.
PMID: 29862210
PMC: 5952530.
DOI: 10.4103/abr.abr_37_17.
Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers.
Iasella S, Stetten A, Corcoran T, Garoff S, Przybycien T, Tilton R
J Aerosol Med Pulm Drug Deliv. 2017; 31(4):212-220.
PMID: 29053080
PMC: 6067685.
DOI: 10.1089/jamp.2017.1412.
History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment.
Yen P, Papin J
PLoS Biol. 2017; 15(8):e2001586.
PMID: 28792497
PMC: 5549691.
DOI: 10.1371/journal.pbio.2001586.
Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Isolates from Burn Patients.
Hosseininassab Nodoushan S, Yadegari S, Moghim S, Nasr Isfahani B, Fazeli H, Poursina F
Adv Biomed Res. 2017; 6:74.
PMID: 28706882
PMC: 5501067.
DOI: 10.4103/abr.abr_239_16.
Microbial Nanoculture as an Artificial Microniche.
Niepa T, Hou L, Jiang H, Goulian M, Koo H, Stebe K
Sci Rep. 2016; 6:30578.
PMID: 27476816
PMC: 4967889.
DOI: 10.1038/srep30578.
Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.
Poole K, Gilmour C, Farha M, Mullen E, Lau C, Brown E
Antimicrob Agents Chemother. 2016; 60(6):3509-18.
PMID: 27021319
PMC: 4879422.
DOI: 10.1128/AAC.03069-15.
Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients.
Ogihara S, Saito R, Akikura T, Iwama A, Adachi Y, Kaji D
Ann Lab Med. 2015; 35(4):410-5.
PMID: 26131412
PMC: 4446579.
DOI: 10.3343/alm.2015.35.4.410.